Showing results (511-520 of 603) with videos related to

Sort By:
Pageof 61
Leukemia|February 10, 2019
Prognostic restaging at the time of second-line therapy in patients with AL amyloidosisYi L Hwa, Morie A Gertz, Shaji K Kumar, et al.
British Journal of Haematology|August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomesJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood Cancer Journal|May 8, 2020
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?M Hasib Sidiqi, Mohammed Aljama, Shaji K Kumar, et al.
Science Translational Medicine|November 24, 2020
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2Alexandra Popa, Jakob-Wendelin Genger, Michael D Nicholson, et al.
Blood|January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Cell Reports|December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Implications of MYC Rearrangements in Newly Diagnosed Multiple MyelomaNadine Abdallah, Linda B Baughn, S Vincent Rajkumar, et al.
Pageof 61